Disruption, adaption and adoption The COVID-19 pandemic has rapidly transformed much of the clinical trials and associated medical device, pharmaceutical, […]
Learn more...COVID-19 FAQ
09/06/2020
COVID-19 FAQ Please find below our most commonly asked questions from the past couple of months. As always if you […]
Learn more...Progress Reporting Change
02/06/2020
Based on feedback from sites and sponsors, and in our aim for continuous improvement, Bellberry has made further attempts to […]
Learn more...Bellberry receives Australian first recognition
27/05/2020
Bellberry awarded AAHRPP accreditation Bellberry has become the first organisation in Australia to achieve international accreditation for excellence and ethically […]
Learn more...Clinical Trials in the time of COVID-19: A case study
21/05/2020
Perth based not-for-profit clinical trial facility, Linear, got early warning on the seriousness of COVID-19 thanks to a staff member […]
Learn more...Beyond COVID-19: A solution focussed forum
19/05/2020
ACTA, PRAXIS, ARCS and CT:IQ collaborate to host clinical trials online forum launching on International Clinical Trials Day, 20 May 2020 […]
Learn more...Challenges in valuing and paying for combination regimens in oncology
08/05/2020
Report of an international workshop convened by Bellberry, held on November 18-20, in Sydney, Australia In November 2019 Bellberry were […]
Learn more...COVID-19 Update: 1 May 2020
01/05/2020
To assist and guide you through this challenging time, Bellberry will continue to gather, distil and deliver the latest information […]
Learn more...Bellberry CEO joins ARCS COVID-19 Webinar
23/04/2020
Earlier this week Bellberry CEO Kylie Sproston joined Tam Nguyen (St Vincent’s Hospital Melbourne) and James Cokayne (NSW Health) to […]
Learn more...PRAXIS Australia free webinar series: Resilience in the era of COVID-19
ENROL NOW! PRAXIS’s small team has received over 1000 enrolments for these sessions and as such processing of registrations may […]
Learn more...COVID-19: Bellberry Planning and Services
18/03/2020
Bellberry has been monitoring the development of the COVID-19 outbreak over the last few weeks. As the Australian situation has […]
Learn more...COVID-19 and Clinical Trials
13/03/2020
Research Participant Welfare & Study Changes As the COVID-19 situation escalates in a number of jurisdictions around the world and […]
Learn more...Four new HREC’s!
21/02/2020
Bellberry is delighted to announce the recent registration and certification of 4 new HRECs H, I, J and K bringing […]
Learn more...Bellberry welcome new staff
Early last year Bellberry adopted the Early Phase Clinical Trial (EPCT) reviews for NSW public health sites and during […]
Learn more...PRAXIS CEO shortlisted for Impact 25 Awards: Vote before Thursday!
12/02/2020
Melanie Gentgall, CEO of Praxis Australia, has been shortlisted for Pro Bono Australia’s Impact 25 awards. These awards seek to […]
Learn more...Bellberry 2020: What’s New?
31/01/2020
Bellberry’s mission is to protect the welfare of research participants and to improve the quality, efficiency and effectiveness of research. […]
Learn more...NSW Early Phase Clinical Trials reach 50 Submissions!
08/01/2020
As we entered 2020 Bellberry celebrated the New Year by reaching our 50th submission for NSW Health Early Phase Clinical […]
Learn more...Christmas and New Year 2019/20
30/12/2019
The Bellberry office will be closed from Tues 24 Dec at 5 pm until Thurs 2 Jan at 9 am. […]
Learn more...New Staff Positions at Bellberry
04/12/2019
Due to the recent addition of Early Phase Clinical Trial (EPCT) reviews for NSW public health sites, organic business growth […]
Learn more...New HREC Officers
27/11/2019
Due to the recent addition of Early Phase Clinical Trial (EPCT) reviews for NSW public health sites, organic business growth […]
Learn more...